tiotropium DPI
Selected indexed studies
- Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI. (Pharmaceutics, 2025) [PMID:41012428]
- Efficacy of tiotropium bromide combined with different doses of fluticasone plus salmeterol DPI in the treatment of stable COPD. (Am J Transl Res, 2021) [PMID:35035721]
- Tiotropium in chronic obstructive pulmonary disease - a review of clinical development. (Respir Res, 2020) [PMID:32727455]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI. (2025) pubmed
- Efficacy of tiotropium bromide combined with different doses of fluticasone plus salmeterol DPI in the treatment of stable COPD. (2021) pubmed
- Tailoring of corticosteroids in COPD management. (2014) pubmed
- Tiotropium in chronic obstructive pulmonary disease - a review of clinical development. (2020) pubmed
- Bioequivalence of Two Tiotropium Dry Powder Inhalers and the Utility of Realistic Impactor Testing. (2023) pubmed
- Long-term safety of tiotropium delivered by Respimat(®) SoftMist™ Inhaler: patient selection and special considerations. (2016) pubmed
- An evaluation of the pharmacokinetics of tiotropium following a single-dose inhalation in healthy subjects using an ultra-sensitive bioanalytical method. (2019) pubmed
- Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. (2007) pubmed
- Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers. (2016) pubmed
- Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. (2011) pubmed